Matsuda, Shigeo
Alnylam Pharmaceuticals (United States)
5 papers on CoChat
Most cited papers
- Verified
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 1,267
- Verified
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
Maier, M. A., Jayaraman, M., Matsuda, S., Liu, J., Barros, S., Querbes, W., Tam, Y. K., Ansell, S. M., Kumar, V., Qin, J., et al. (2013) · Molecular Therapy
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 625
- Verified
Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
Brown, C. R., Gupta, S., Qin, J., Racie, T., He, G., Lentini, S., Malone, R., Yu, M., Matsuda, S., Shulga-Morskaya, S., et al. (2020) · Nucleic Acids Research
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 285
- Verified
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
Brown, K. M., Nair, J. K., Janas, M. M., Anglero-Rodriguez, Y. I., Dang, L. T. H., Peng, H., Theile, C. S., Castellanos-Rizaldos, E., Brown, C., Foster, D., et al. (2022) · Nature Biotechnology
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 258
- Verified
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 150
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free